Navigation Links
Genentech's Winning Streak

The firm's shares shot up 40% this morning after it announced that Avastin, which many analysts consider the most important drug in the company's pipeline, has been found to extend the lives of colon cancer patients.

Late last week, new data and a regulatory decision buttressed the outlook for medicines that Genentech (nyse:
Full article >>> the survival times of colon-cancer patients. Second, the patients lived even longer than researchers had hoped when designing the trial. Third, the only significant side effect to emerge in late-stage trials was high blood pressure. (Gastrointestinal bleeding is still listed as a possible, though uncommon, side effect.)

Those three pieces of information were enough to clear away skeptici......

Full article >>> tory watchdogs.

Genentech's strategy may have been high risk, as some analysts said. But now the company looks poised to reap some big rewards.......

Full article >>>
'"/>

Source:wistechnology.com By Matthew Herper 05/19/03


Related biology technology :

1. Winning and losing in the brain gain game
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2016)... Francisco, CA (PRWEB) , ... April 26, 2016 , ... ... division for Adecco RPO, signing the first multi-million dollar, multi-year managed services contract in ... delighted to have Michael join our leadership team,” said John Younger, founder of Accolo. ...
(Date:4/26/2016)... ... ... BioFactura, Inc ., a biopharmaceutical research and manufacturing company, announced today the ... significant oversubscription of the original $1.5M target. The funds will be used to ... , Chief Executive Officer and President, Darryl Sampey founded BioFactura in 2004 ...
(Date:4/26/2016)... , VIENNA and ... The prize recognizes the ... resulting revolutionary innovations that will benefit patients and ... http://photos.prnewswire.com/prnh/20160210/331945LOGO ) , Norma ... proprietary trend setting products in the field of ...
(Date:4/26/2016)... ... April 26, 2016 , ... The Institute for Venture ... round of pre-proposal competition for scientific grants. , The IVS funds promising ideas ... the highest potential to replace paradigms that have outlived their usefulness. All areas ...
Breaking Biology Technology:
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):